{"disease":{"id":"dengue-fever","name":"dengue fever"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06843226","title":"A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue","phase":"","overall_status":"RECRUITING","enrollment_count":70000,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06268691","title":"Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating","phase":"NA","overall_status":"COMPLETED","enrollment_count":35000,"lead_sponsor_name":"Rocio Cardenas Sanchez","has_results":false},{"nct_id":"NCT02948933","title":"Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine","phase":"","overall_status":"COMPLETED","enrollment_count":30000,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT01373281","title":"Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":10275,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT07543458","title":"Therapeutics for Moderate and Severe Dengue","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":8800,"lead_sponsor_name":"Oxford University Clinical Research Unit, Vietnam","has_results":false},{"nct_id":"NCT03055585","title":"Applying Wolbachia to Eliminate Dengue","phase":"NA","overall_status":"TERMINATED","enrollment_count":8173,"lead_sponsor_name":"Gadjah Mada University","has_results":false},{"nct_id":"NCT04514107","title":"A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)","phase":"NA","overall_status":"COMPLETED","enrollment_count":5757,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05218304","title":"Baromètre Santé Adulte 2021-2022","phase":"NA","overall_status":"SUSPENDED","enrollment_count":5471,"lead_sponsor_name":"Agence Sanitaire et Sociale de Nouvelle Calédonie","has_results":false},{"nct_id":"NCT07520279","title":"Xpert® Tropical Fever Test on GeneXpert® Edge X System","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2500,"lead_sponsor_name":"Cepheid","has_results":false},{"nct_id":"NCT06388785","title":"A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT02302066","title":"Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1800,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02628444","title":"Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1050,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02193087","title":"Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1002,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT07432061","title":"Prediction of Infectious Diseases in LMICs Using Electronic Health Record Data","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT03423173","title":"Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":923,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04113330","title":"Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":918,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT07112846","title":"Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":830,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT06579755","title":"A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03534245","title":"Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children","phase":"","overall_status":"COMPLETED","enrollment_count":775,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02992418","title":"Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":688,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03620487","title":"Detection of Dengue Virus in Plasma of Patients in Nepal","phase":"","overall_status":"COMPLETED","enrollment_count":643,"lead_sponsor_name":"Karius, Inc.","has_results":false},{"nct_id":"NCT04989673","title":"Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French Guiana","phase":"","overall_status":"COMPLETED","enrollment_count":628,"lead_sponsor_name":"Centre Hospitalier de Cayenne","has_results":false},{"nct_id":"NCT04313244","title":"Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":614,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03206541","title":"Neurologic Manifestations of the Arbovirus Infection in Colombia","phase":"","overall_status":"COMPLETED","enrollment_count":570,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT02993757","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":528,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT04235361","title":"Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University of Stirling","has_results":false},{"nct_id":"NCT06877039","title":"Characteristics of Clinical Laboratory Indicators in Patients with Dengue Fever","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Foshan Hospital of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT07047521","title":"A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":496,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT02979535","title":"Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT05580731","title":"Evaluation Study of Dengue RDTs","phase":"","overall_status":"COMPLETED","enrollment_count":430,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT01488890","title":"Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03999996","title":"Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":365,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02425098","title":"Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04422782","title":"New Tools for Predicting Capillary Leak Shock During Dengue Fever","phase":"NA","overall_status":"UNKNOWN","enrollment_count":342,"lead_sponsor_name":"Centre Hospitalier de Cayenne","has_results":false},{"nct_id":"NCT02827162","title":"Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine","phase":"","overall_status":"COMPLETED","enrollment_count":334,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT06697041","title":"Clinical and Laboratory Factors for the Progression of Severe Dengue Among Hospitalized Patients During an Upsurge","phase":"","overall_status":"COMPLETED","enrollment_count":324,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT06642493","title":"Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sheikh Hasina National Institute of Burn and Plastic Surgery","has_results":false},{"nct_id":"NCT00788151","title":"Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT04434846","title":"Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06744777","title":"The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Khyber Medical University Peshawar","has_results":false},{"nct_id":"NCT05607472","title":"Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":258,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT02623725","title":"Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03632486","title":"Bedside Ultrasound Predicts Progression of Severity of Disease in Dengue Fever","phase":"","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Timothy Gleeson","has_results":false},{"nct_id":"NCT06665035","title":"A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":212,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03771963","title":"Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04048837","title":"Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"National University Hospital, Singapore","has_results":false},{"nct_id":"NCT06741683","title":"A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06945679","title":"Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","has_results":false},{"nct_id":"NCT06859619","title":"Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":183,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}